UA118497C2 - METHOD OF TREATMENT OF CHILDREN WITH SPINAL MUSCLE ATROPHY TYPE III BY PREPARATIONS OF MATERIAL OF EMBRYOPHETAL ORIGIN AND ILLUSTRATED FROM - Google Patents
METHOD OF TREATMENT OF CHILDREN WITH SPINAL MUSCLE ATROPHY TYPE III BY PREPARATIONS OF MATERIAL OF EMBRYOPHETAL ORIGIN AND ILLUSTRATED FROMInfo
- Publication number
- UA118497C2 UA118497C2 UAA201704100A UAA201704100A UA118497C2 UA 118497 C2 UA118497 C2 UA 118497C2 UA A201704100 A UAA201704100 A UA A201704100A UA A201704100 A UAA201704100 A UA A201704100A UA 118497 C2 UA118497 C2 UA 118497C2
- Authority
- UA
- Ukraine
- Prior art keywords
- type iii
- children
- stem cells
- embryophetal
- preparations
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Винахід належить до способу лікування дітей зі спінальною м'язовою атрофією III типу, шляхом приготування та введення щонайменше двох препаратів з матеріалу ембріофетального походження та виділених з нього клітин, де перший препарат являє собою суспензію стовбурових клітин з фетальної печінки, та другий препарат являє собою суспензію стовбурових клітини фетального головного мозку, причому вказані суспензії стовбурових клітин вводять одночасно з проведенням стандартної терапії, а перед введенням суспензії стовбурових клітин з фетальної печінки додатково виконують премедикацію.The invention relates to a method of treating children with spinal muscular atrophy type III, by preparing and administering at least two drugs from embryo-fetal material and isolated cells, where the first drug is a suspension of stem cells from fetal liver, and the second drug is a suspension fetal brain stem cells, and these suspensions of stem cells are administered simultaneously with standard therapy, and before the introduction of a suspension of stem cells from the fetal liver additionally perform premedication.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA201704100A UA118497C2 (en) | 2017-04-25 | 2017-04-25 | METHOD OF TREATMENT OF CHILDREN WITH SPINAL MUSCLE ATROPHY TYPE III BY PREPARATIONS OF MATERIAL OF EMBRYOPHETAL ORIGIN AND ILLUSTRATED FROM |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA201704100A UA118497C2 (en) | 2017-04-25 | 2017-04-25 | METHOD OF TREATMENT OF CHILDREN WITH SPINAL MUSCLE ATROPHY TYPE III BY PREPARATIONS OF MATERIAL OF EMBRYOPHETAL ORIGIN AND ILLUSTRATED FROM |
Publications (1)
Publication Number | Publication Date |
---|---|
UA118497C2 true UA118497C2 (en) | 2019-01-25 |
Family
ID=74214458
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201704100A UA118497C2 (en) | 2017-04-25 | 2017-04-25 | METHOD OF TREATMENT OF CHILDREN WITH SPINAL MUSCLE ATROPHY TYPE III BY PREPARATIONS OF MATERIAL OF EMBRYOPHETAL ORIGIN AND ILLUSTRATED FROM |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA118497C2 (en) |
-
2017
- 2017-04-25 UA UAA201704100A patent/UA118497C2/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019011215A (en) | Nucleic acids encoding crispr-associated proteins and uses thereof. | |
EA201890725A1 (en) | PHARNESIDE X-RECEPTOR AGONISTS AND THEIR APPLICATION | |
MY191040A (en) | Therapy involving antibodies against claudin 18.2 for treatment of cancer | |
AU2017291414B2 (en) | Anti-N3pGLu amyloid beta peptide antibodies and uses thereof | |
MX2016009231A (en) | Administration of tasimelteon under fasted conditions. | |
EA201992083A1 (en) | SOMATOSTATIN MODULATORS AND THEIR APPLICATION | |
EA201791535A1 (en) | NEW CONNECTION 4'-TIONOUCLEOSIDE, AND ALSO THE WAY OF ITS OBTAINING, ITS PHARMACEUTICAL COMPOSITION AND APPLICATION | |
RU2017134443A (en) | METHOD OF TREATMENT WITH USE OF TRADIPTANT | |
EA202290024A1 (en) | METHODS FOR THE TREATMENT OF FABRY DISEASE IN PATIENTS WITH RENAL INSUFFICIENCY | |
JOP20210323A1 (en) | Multispecific heavy chain antibodies binding to cd22 and cd3 | |
MX2022004678A (en) | Anti-beta-amyloid antibody for treating alzheimer's disease. | |
BR112019006216A2 (en) | p2x3 and / or p2x2 / 3 compounds and methods | |
EA202092540A1 (en) | COMBINATIONS FOR CANCER TREATMENT | |
UA118497C2 (en) | METHOD OF TREATMENT OF CHILDREN WITH SPINAL MUSCLE ATROPHY TYPE III BY PREPARATIONS OF MATERIAL OF EMBRYOPHETAL ORIGIN AND ILLUSTRATED FROM | |
JOP20190019A1 (en) | PHARMACEUTICAL COMPOSITION FOR TREATING GROWTH HORMONE DEFICIENCY CONTAINING hGH FUSION PROTEIN | |
MX2022004382A (en) | Methods of promoting scfa production by gut microbiota. | |
WO2016130518A3 (en) | Methods and compositions for treating muscle disease and disorders | |
MX2021008081A (en) | Treatment of sjogren's disease with nuclease fusion proteins. | |
MX2021006242A (en) | Capsule formulations. | |
WO2020086479A9 (en) | Dosing | |
CA3199014A1 (en) | Combination therapy for the treatment of a liver disease | |
JOP20170044B1 (en) | Pharmaceutical composition comprising recombinant hgh for the treatment of growth hormone deficiency | |
MX2021015338A (en) | Composition comprising pridopidine and analog thereof for treating huntington disease and symptoms thereof. | |
AU2020360413A8 (en) | Methods of treating conditions related to the S1P1 receptor | |
WO2021099966A3 (en) | Novel benzothiophene derivatives and use thereof for stimulating mitochondrial turnover |